In vitro activity of ceftobiprole against aerobic and anaerobic strains isolated from diabetic foot infections

被引：52

作者：

Goldstein, Ellie J. C.

Citron, Diane M.

Merriam, C. Vreni

Warren, Yumi A.

Tyrrell, Kerin L.

Fernandez, Helen T.

机构：

[1] RM Alden Res Lab, Santa Monica, CA 90404 USA

[2] Univ Calif Los Angeles, Sch Med, Los Angeles, CA 90073 USA

来源：

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY | 2006年 / 50卷 / 11期

关键词：

SPECTRUM PYRROLIDINONE CEPHALOSPORIN; BAL9141; BACTERIA;

D O I：

10.1128/AAC.00722-06

中图分类号：

Q93 [微生物学];

学科分类号：

071005 ; 100705 ;

摘要：

Against 443 aerobic and anaerobic bacteria isolated from diabetic foot infections, ceftobiprole MICs (mu g/ml) at which 90% of the isolates tested were inhibited were as follows: methicillin-resistant Staphylococcus aureus, 1; methicillin-susceptible S. aureus and Staphylococcus lugdunensis, 0.5; Anaerococcus prevotii, 0.125; Finegoldia magna, 0.5; Peptoniphilus asaccharolyticus, 1; Peptostreptococcus anaerobius, 4; Escherichia coli and Enterobacter species, 0.125; Klebsiella species, 2; and Pseudomonas aeruginosa, 8.

引用

页码：3959 / 3962

页数：4

共 15 条

[1] *AM DIAB ASS, 2006, LAT HLTH CAR DIAB LA
[2] [Anonymous], 2003, METHODS DILUTION ANT
[3] PATTERNS OF FOOT EXAMINATION IN A DIABETES CLINIC
BAILEY, TS
YU, HM
RAYFIELD, EJ
[J]. AMERICAN JOURNAL OF MEDICINE, 1985, 78 (03) : 371 - 374
[4] Antistaphylococcal activity of ceftobiprole, a new broad-spectrum cephalosporin
Bogdanovich, T
Ednie, LM
Shapiro, S
Appelbaum, PC
[J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2005, 49 (10) : 4210 - 4219
[5] *CLIN LAB STAND I, 2006, METH ANT DIL DISK DI
[6] Bactericidal activity of BAL9141, a novel parenteral cephalosporin against contemporary Gram-positive and Gram-negative isolates
Deshpande, L
Rhomberg, PR
Fritsche, TR
Sader, HS
Jones, RN
[J]. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2004, 50 (01) : 73 - 75
[7] FOOT INFECTIONS IN DIABETIC-PATIENTS - THE ROLE OF ANAEROBES
GERDING, DN
[J]. CLINICAL INFECTIOUS DISEASES, 1995, 20 : S283 - S288
[8] Diabetic foot infections. Bacteriology and activity of 10 oral antimicrobial agents against bacteria isolated from consecutive cases
Goldstein, EJC
Citron, DM
Nesbit, CA
[J]. DIABETES CARE, 1996, 19 (06) : 638 - 641
[9] In vitro and in vivo properties of Ro 63-9141, a novel broad-spectrum cephalosporin with activity against methicillin-resistant staphylococci
Hebeisen, P
Heinze-Krauss, I
Angehrn, P
Hohl, P
Page, MGP
Then, RL
[J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2001, 45 (03) : 825 - 836
[10] In vitro activity of BAL9141 against clinical isolates of gram-negative bacteria
Issa, NC
Rouse, MS
Piper, KE
Wilson, WR
Steckelberg, JM
Patel, R
[J]. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2004, 48 (01) : 73 - 75

← 1 2 →